Cargando…
CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia
[Figure: see text]
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840233/ https://www.ncbi.nlm.nih.gov/pubmed/35500285 http://dx.doi.org/10.1182/bloodadvances.2021006810 |
| _version_ | 1784869599325454336 |
|---|---|
| author | Wintering, Astrid Ishiyama, Kenichi Tamaki, Stanley Tamaki, Courtney Fandel, Joshua Ji, Lingyun Wood, Brent L. Shah, Nirali N. Yuan, Constance M. O’Brien, Maureen M. Loh, Mignon L. Diaz-Flores, Ernesto |
| author_facet | Wintering, Astrid Ishiyama, Kenichi Tamaki, Stanley Tamaki, Courtney Fandel, Joshua Ji, Lingyun Wood, Brent L. Shah, Nirali N. Yuan, Constance M. O’Brien, Maureen M. Loh, Mignon L. Diaz-Flores, Ernesto |
| author_sort | Wintering, Astrid |
| collection | PubMed |
| description | [Figure: see text] |
| format | Online Article Text |
| id | pubmed-9840233 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98402332023-01-19 CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia Wintering, Astrid Ishiyama, Kenichi Tamaki, Stanley Tamaki, Courtney Fandel, Joshua Ji, Lingyun Wood, Brent L. Shah, Nirali N. Yuan, Constance M. O’Brien, Maureen M. Loh, Mignon L. Diaz-Flores, Ernesto Blood Adv Research Letter [Figure: see text] The American Society of Hematology 2022-05-05 /pmc/articles/PMC9840233/ /pubmed/35500285 http://dx.doi.org/10.1182/bloodadvances.2021006810 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Wintering, Astrid Ishiyama, Kenichi Tamaki, Stanley Tamaki, Courtney Fandel, Joshua Ji, Lingyun Wood, Brent L. Shah, Nirali N. Yuan, Constance M. O’Brien, Maureen M. Loh, Mignon L. Diaz-Flores, Ernesto CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia |
| title | CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia |
| title_full | CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia |
| title_fullStr | CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia |
| title_full_unstemmed | CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia |
| title_short | CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia |
| title_sort | cd22(low)/bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840233/ https://www.ncbi.nlm.nih.gov/pubmed/35500285 http://dx.doi.org/10.1182/bloodadvances.2021006810 |
| work_keys_str_mv | AT winteringastrid cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT ishiyamakenichi cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT tamakistanley cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT tamakicourtney cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT fandeljoshua cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT jilingyun cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT woodbrentl cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT shahniralin cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT yuanconstancem cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT obrienmaureenm cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT lohmignonl cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia AT diazfloresernesto cd22lowbcl2highexpressionidentifiespoorresponsetoinotuzumabozogamicininrelapsedrefractoryacutelymphoblasticleukemia |